COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 960: Articles 9591-9600  | Next

Effectiveness of Covid-19 Vaccines against the SARS-COV-2-Delta (B.1.617.2) in China-A Real World Study
Ma, X., Han, J., Li, H., Liu, C.
10.1101/2022.02.07.22270490 — Posted: 2022-02-08
Validating saliva as a biological sample for cost-effective, rapid and routine screening for SARS-CoV-2
Ansil, B. R., George, C. E., Chandrasingh, S., Viswanathan, A., Thattai, M., Raghu, P., Devadiga, S., Harikumar, A. G., Harsha, P. K., Nair, I., Ramakrishnan, U., Mayor, S.
10.1101/2022.02.07.22269889 — Posted: 2022-02-08
Changes in the number of public health nurses employed in local governments in Japan during the Covid-19 pandemic: A cross-sectional study
Taira, K., Hosokawa, R., Shiomi, M.
10.1101/2022.02.06.22270346 — Posted: 2022-02-08
COVID-19 outbreaks in Australia during a period of high epidemic control, 2020
Hogarth, F. G., Nye, R., Pingault, N., Crouch, S., Coffey, C., Smith, K., Boyd, R., Kelaher, C., Reinten, T., Hewitt, M. C., Polkinghorne, B., Kirk, M.
10.1101/2022.02.07.22270575 — Posted: 2022-02-07
SARS-CoV-2 mRNA vaccination fails to elicit humoral and cellular immune responses in multiple sclerosis patients receiving fingolimod
Meyer-Arndt, L., Braun, J., Fauchere, F., Vanshylla, K., Loyal, L., Henze, L., Kruse, B., Dingeldey, M., Juerchott, K., Mangold, M., Maraj, A., Braginets, A., Boettcher, C., Nitsche, A., de la Rosa, K., Ratswohl, C., Sawitzki, B., Holenya, P., Reimer, U., Sander, L. E., Klein, F., Paul, F., Bellmann-Strobl, J., Thiel, A., Giesecke-Thiel, C.
10.1101/2022.02.06.22270550 — Posted: 2022-02-07
Estimating the risk reduction of isolation on COVID-19 non-household transmission and severe/critical illness in non-immune individuals: September to November 2021
Prosser, A., Helfer, B., Streiner, D. L.
10.1101/2022.02.05.22270453 — Posted: 2022-02-07
Cross-Sectional Study of University students attitudes to on campus delivery of COVID-19 vaccines and future-proofing MenACWY and MMR vaccination rates by adopting COVID-19 vaccine roll-out strategies
Webb, A., Gogoi, M. D., Weidman, S., Woolf, K., Zavala, M., Ladhani, S., Pareek, M., Gies, L., Bayliss, C. D.
10.1101/2022.02.07.22270394 — Posted: 2022-02-07
Food insecurity disparities and mental health impacts among cancer survivors during the COVID-19 pandemic
Camacho-Rivera, M., Islam, J. Y., Rodriguez, D. R., Vidot, D. C., Bailey, Z. D.
10.1101/2022.02.06.22270283 — Posted: 2022-02-07
Protection of COVID-19 vaccination and previous infection against Omicron BA.1 and Delta SARS-CoV-2 infections, the Netherlands, 22 November 2021- 19 January 2022
Andeweg, S. P., de Gier, B., Eggink, D., van den Ende, C., van Maarseveen, N., Ali, L., Vlaemynck, B., Schepers, R., RIVM COVID-19 surveillance and epidemiology team, , Hahne, S. J. M., Reusken, C., de Melker, H. E., van den Hof, S., Knol, M. J.
10.1101/2022.02.06.22270457 — Posted: 2022-02-07 Discussion: Onsite
Molecular markers for early stratification of disease severity and progression in COVID-19
Kashyap, A., Sebastian, S. A., N., R., K., R., H., K., Krishna, B., DSouza, G., Idiculla, J., Vyas, N.
10.1101/2022.02.06.22270355 — Posted: 2022-02-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).